NIH Clinical Trial Supported by CTSA Program Hubs Shows Improved Survival for People Hospitalized with COVID-19
Preliminary results from the ACTIV-1 Immune Modulator clinical trial show that immune modulator drugs, infliximab and abatacept, substantially improved clinical status and reduced deaths in adults hospitalized with COVID-19. The National Institutes of Health (NIH)...
Launch of i3 Prism, a Technology Commercialization Fund Focused on Women and BIPOC Health Care Innovators
Mount Sinai Innovation Partners (MSIP), the commercialization arm of the Mount Sinai Health System, is pleased to announce the launch of i3 Prism, an early-stage technology commercialization fund focused on women and Black, Indigenous and people of color (BIPOC)...
ConduITS the Clinical & Translational Science Award (CTSA) Program for the Mount Sinai Health System is proud to announce that one of Mount Sinai’s leading COVID-19 experts Judith A. Aberg, MD, the Chief of Infectious Diseases (ID) for the Mount Sinai Healthcare...
The Office of Research Services (ORS) and ConduITS Institute for Translational Sciences at the Icahn School of Medicine at Mount Sinai has recently added two new CITI Program learning modules for clinical research coordinators (or anyone at Mount Sinai) to access for...
In partnership with the Icahn School of Medicine at Mount Sinai Science magazine recently published a supplement titled “The Frontiers of Medical Research.” The supplement includes 17 articles prepared by Mount Sinai researchers, physicians, and educators that...
What is ConduITS?
ConduITS is the Clinical & Translational Science Award (CTSA) Program for the Mount Sinai Health System established in 2009 with funding from the National Institutes of Health (NIH), NCATS. LEARN MORE >
CTSA MSHS EVENTS
Digital Concierge Service - Informatics and Data Science Online Clinics
Every Wednesday 3:30 - 4:30 PM
Join virtual room
CTSA NETWORK EVENTS & RESOURCES
Trial Innovation Network (TIN) Events
Webinars, Forums and Meetings on Multi-Site Clinical Studies
For additional help submit a Research 411 ticket.
Mount Sinai CTSA Featured Trainees
Bridget Marcellino, MD, PhD is a former CTSA KL2 scholar and now an Assistant Professor in the Tisch Cancer Institute at Mount Sinai specializing in myeloproliferative neoplasms and leukemia. Myeloproliferative Neoplasms are chronic blood disorders that are associated...
Francesca Stillitano, Ph.D, is an Assistant Professor of Medicine in the Cardiovascular Research Center at the Icahn School of Medicine at Mount Sinai and a third year KL2 scholar. Her work focuses on using human induced pluripotent stem cells to model cardiac...
EMERGING INVESTIGATORS PROGRAM
- Enhancing your career
- Mentorship and networking
- Professional development
- Research skills and resources
Sign up for the Research Listserv to receive the latest MSHS research news and events.